SEQ came out with their 1HFY23 Investor presentation after market close.
The summary is weak top line growth, salved in part by improving margins. The "abnormal" items (flagged previously) however resulted in a weak NPAT result of only $600k for the half. The market, in its infinite wisdom, was already anticipating numbers like this with the shares hurtling towards their 52w lows.
Management is forecasting a much improved second half, so it comes down to how much trust the market places in that prognostication. Given the recent track record though, some jitters won't be surprising in the least.
Overall, this is a thesis-weakening result, though not a thesis-busting one.